Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Infectious Disease

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1777729

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1777729

Acute Bacterial Skin and Skin Structure Infections

PUBLISHED:
PAGES: 355 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Acute Bacterial Skin and Skin Structure Infections Market to Reach US$1.5 Billion by 2030

The global market for Acute Bacterial Skin and Skin Structure Infections estimated at US$1.3 Billion in the year 2024, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 2.7% over the analysis period 2024-2030. Community-Acquired ABSSI, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Hospital- Acquired ABSSI segment is estimated at 4.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$349.8 Million While China is Forecast to Grow at 5.2% CAGR

The Acute Bacterial Skin and Skin Structure Infections market in the U.S. is estimated at US$349.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$291.5 Million by the year 2030 trailing a CAGR of 5.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.0% and 2.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.5% CAGR.

Global Acute Bacterial Skin and Skin Structure Infections Market - Key Trends & Drivers Summarized

What Are ABSSSIs, and Why Is Their Management Crucial in Modern Healthcare?

Acute bacterial skin and skin structure infections encompass a broad spectrum of serious bacterial infections, including cellulitis, abscesses, and wound infections. These conditions often result from pathogens such as Staphylococcus aureus, including its methicillin-resistant strain (MRSA), and Streptococcus pyogenes, posing significant challenges for effective treatment. The management of ABSSSIs has gained critical importance due to their rising prevalence, driven by factors such as an aging global population, the increasing prevalence of diabetes, and the growing number of surgical procedures. These infections, if not treated promptly, can lead to severe complications, including sepsis and prolonged hospital stays, placing a significant burden on healthcare systems worldwide. The development of targeted therapies and advanced antibiotics has become essential in combating ABSSSIs, offering solutions that address antimicrobial resistance while ensuring rapid and effective patient recovery.

How Are Innovations in Antibiotic Therapies Revolutionizing ABSSSI Treatment?

The treatment landscape for ABSSSIs has witnessed substantial innovation, with the development of new-generation antibiotics and novel delivery systems aimed at improving efficacy and patient outcomes. Traditional antibiotics such as vancomycin and daptomycin continue to be widely used; however, the emergence of resistant strains has necessitated the introduction of advanced alternatives. Novel agents like tedizolid, dalbavancin, and oritavancin have shown promising results, offering enhanced activity against resistant pathogens, reduced dosing frequency, and fewer side effects. Additionally, combination therapies have emerged as effective strategies to combat multi-drug-resistant organisms by targeting different bacterial mechanisms. Innovations in drug delivery, such as long-acting formulations and injectable antibiotics, have improved patient compliance and reduced hospital admissions. Moreover, advancements in rapid diagnostic tools have facilitated the early identification of pathogens, enabling personalized treatment approaches and minimizing the overuse of broad-spectrum antibiotics. These developments are significantly enhancing the standard of care for ABSSSI patients.

Which Regions and Patient Demographics Are Driving Market Demand?

The demand for ABSSSI treatments varies significantly across regions, shaped by differences in healthcare access, prevalence of resistant pathogens, and disease awareness. North America and Europe are leading markets for ABSSSI therapies, driven by advanced healthcare infrastructure, high diagnostic rates, and a strong focus on antimicrobial stewardship. The growing incidence of hospital-acquired infections and surgical site infections in these regions has further fueled the adoption of novel antibiotics and targeted therapies. The Asia-Pacific region, however, is emerging as a key growth market due to its large population base, rising healthcare expenditures, and increasing prevalence of infectious diseases. Countries like China and India are particularly prominent, with expanding healthcare infrastructures and heightened awareness of antibiotic resistance challenges. Within patient demographics, individuals with compromised immune systems, such as those with diabetes, HIV, or undergoing chemotherapy, represent a significant portion of the market demand. Additionally, the aging population and the growing number of patients with chronic wounds and pressure ulcers are contributing to the increased prevalence of ABSSSIs worldwide.

What Factors Are Driving Growth in the ABSSSI Market?

The growth in the Acute Bacterial Skin and Skin Structure Infections market is driven by several factors, including the increasing prevalence of drug-resistant pathogens, advancements in antibiotic development, and growing awareness of infectious disease management. The rise of resistant strains such as MRSA has heightened the demand for innovative therapies that address the limitations of traditional antibiotics. Advances in targeted therapies, including new antibiotics and combination treatments, have provided effective solutions to combat challenging infections. The increasing prevalence of chronic conditions such as diabetes, which predispose individuals to ABSSSIs, has also fueled market growth. Expanding healthcare access in emerging markets, combined with government initiatives to combat antimicrobial resistance, has further supported the adoption of advanced treatment solutions. Additionally, investments in R&D by pharmaceutical companies and the introduction of faster diagnostic tools have enhanced early detection and treatment efficacy, ensuring sustained growth in the global ABSSSI market.

SCOPE OF STUDY:

The report analyzes the Acute Bacterial Skin and Skin Structure Infections market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Infection Type (Community-Acquired ABSSI, Hospital- Acquired ABSSI); Route of Administration (Oral Administration, Parenteral Administration, Topical Administration); Distribution Channel (Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 25 Featured) -

  • AbbVie, Inc.
  • Basilea Pharmaceutica Ltd.
  • Cipher Pharmaceuticals Inc.
  • Cumberland Pharmaceuticals Inc.
  • Melinta Therapeutics LLC
  • MicuRx Pharmaceuticals, Inc.
  • Nabriva Therapeutics plc
  • Paladin Labs Inc.
  • Paratek Pharmaceuticals, Inc.
  • Recce Pharmaceuticals Ltd.
  • Teva Pharmaceutical Industries Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP28972

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Acute Bacterial Skin and Skin Structure Infections - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Complicated SSTIs Drives Demand for Broad-Spectrum Antibacterial Therapeutics
    • Expansion of Outpatient Parenteral Antibiotic Therapy Throws the Spotlight on Long-Acting IV Antibiotics
    • Increased Prevalence of MRSA and Drug-Resistant Pathogens Spurs Innovation in Novel Antibacterial Agents
    • OEM Focus on Once-Daily and Dual-Action Therapies Strengthens Patient Adherence and Treatment Efficiency
    • Regulatory Fast-Track and Priority Review Pathways Accelerate Launch of First-in-Class SSTI Drugs
    • Growing Clinical Preference for IV-to-Oral Switch Therapies Expands Use of Oral Agents in Moderate Infections
    • Integration of Rapid Diagnostic Tools Enhances Early Pathogen Identification and Antibiotic Stewardship
    • Hospital-Acquired SSTI Risk Reduction Protocols Drive Demand for Evidence-Based Treatment Algorithms
    • Emergence of Biosimilars and Non-Beta-Lactam Alternatives Expands Formulary Choices in Resistant Cases
    • Surge in Emergency Department Presentations for SSTIs Spurs Need for Immediate-Acting Therapeutics
    • OEM Development of Narrow-Spectrum Antibiotics Reduces Collateral Damage to Microbiome
    • Rising Incidence of Post-Surgical and Device-Related SSTIs Propels Hospital-Initiated Antibiotic Protocols
    • Global Antimicrobial Resistance Mitigation Programs Encourage Use of Targeted SSTI Regimens
    • Growth in Diabetic and Immunocompromised Populations Strengthens Demand for Fast-Acting Antibiotic Coverage
    • Use of Real-World Data From Electronic Medical Records Enhances Drug Effectiveness Analysis
    • Availability of Once-Weekly and Depot Antibiotic Therapies Supports Outpatient Management Models
    • Increasing Investment in Dual-Pathogen Trials and Multi-Organism Coverage Expands Drug Utility
    • Health System Push for Cost Containment and Shorter Hospital Stays Drives Oral Antibiotic Adoption
    • Surge in SSTI-Related Hospitalizations in Emerging Markets Propels Access to Advanced Therapeutics
    • Public and Professional Awareness Campaigns Support Early Recognition and Prompt Antibiotic Intervention
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Acute Bacterial Skin and Skin Structure Infections Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Acute Bacterial Skin and Skin Structure Infections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Community-Acquired ABSSI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Community-Acquired ABSSI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Community-Acquired ABSSI by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hospital- Acquired ABSSI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Hospital- Acquired ABSSI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Hospital- Acquired ABSSI by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Oral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Parenteral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Parenteral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Parenteral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Topical Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Topical Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Topical Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospital Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospital Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospital Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Retail Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Retail Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Retail Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Online Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Online Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Online Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Acute Bacterial Skin and Skin Structure Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • JAPAN
    • Acute Bacterial Skin and Skin Structure Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • CHINA
    • Acute Bacterial Skin and Skin Structure Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • EUROPE
    • Acute Bacterial Skin and Skin Structure Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Acute Bacterial Skin and Skin Structure Infections by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • FRANCE
    • Acute Bacterial Skin and Skin Structure Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • GERMANY
    • Acute Bacterial Skin and Skin Structure Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Acute Bacterial Skin and Skin Structure Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Spain 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Russia 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Acute Bacterial Skin and Skin Structure Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Acute Bacterial Skin and Skin Structure Infections by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Acute Bacterial Skin and Skin Structure Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Australia 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • INDIA
    • Acute Bacterial Skin and Skin Structure Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: India 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: South Korea 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Acute Bacterial Skin and Skin Structure Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Acute Bacterial Skin and Skin Structure Infections by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Latin America 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Argentina 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Brazil 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Mexico 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Rest of Latin America 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Acute Bacterial Skin and Skin Structure Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Acute Bacterial Skin and Skin Structure Infections by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Middle East 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Iran 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Israel 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Saudi Arabia 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: UAE 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Rest of Middle East 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • AFRICA
    • Acute Bacterial Skin and Skin Structure Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Africa 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!